We hypothesized that ROS levels increase in circulating tumor cells at the early stage of tumor cell entry into the liver and induce slight caspase-3 activation, which cleaves GSDME proteins to punch holes in the tumor cell membrane. This evidence concerns the gene GSDME and neoplasm.